Curanex Pharmaceuticals Inc
Developing botanical drugs for inflammatory diseases, diabetes, and COVID-19.
CURX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 2 JERICHO PLAZA,, 11753 JERICHO
- Website:
- https://www.curanexpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Curanex Pharmaceuticals Inc. is a developmental-stage pharmaceutical company dedicated to discovering, developing, and commercializing innovative botanical drugs. The company focuses on creating treatments for patients with unmet medical needs, particularly for inflammatory diseases. Its drug development pipeline targets various therapeutic areas, with a primary focus on ulcerative colitis, atopic dermatitis, COVID-19, and diabetes. Founded in 1996, Curanex aims to validate the efficacy of its botanical compounds through clinical research and development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Curanex Pharmaceuticals Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Curanex Pharmaceuticals Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Curanex Pharmaceuticals Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20LTD/other/Cuprina_Holdings_Cayman_LTD-logo.png){kind=logo}
